BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36032834)

  • 1. Low Dose Intratympanic Gentamicin in Ménière's Disease.
    Faizal B; Rajan A
    Indian J Otolaryngol Head Neck Surg; 2022 Aug; 74(Suppl 1):320-325. PubMed ID: 36032834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
    Öztürk K; Ata N
    Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
    Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
    Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin for Ménière's disease.
    Webster KE; Galbraith K; Lee A; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015246. PubMed ID: 36847592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease.
    Abou-Halawa AS; Poe DS
    Otol Neurotol; 2002 Jul; 23(4):494-502; discussion 502-3. PubMed ID: 12170152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
    Patel M; Agarwal K; Arshad Q; Hariri M; Rea P; Seemungal BM; Golding JF; Harcourt JP; Bronstein AM
    Lancet; 2016 Dec; 388(10061):2753-2762. PubMed ID: 27865535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing.
    Thomas L; Lepcha A; Reka K; Augustine AM; Alex A; Philip A; Mammen MD
    Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):3738-3745. PubMed ID: 36742746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamicin treatment after endolymphatic sac surgery.
    Gouveris H; Lange G; Mann WJ
    Acta Otolaryngol; 2005 Nov; 125(11):1180-3. PubMed ID: 16353396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis.
    Chia SH; Gamst AC; Anderson JP; Harris JP
    Otol Neurotol; 2004 Jul; 25(4):544-52. PubMed ID: 15241234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of intractable Ménière's disease after intratympanic injection of gentamicin.
    Rah YC; Han JJ; Park J; Choi BY; Koo JW
    Laryngoscope; 2015 Apr; 125(4):972-8. PubMed ID: 25363447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic gentamicin for Ménière's disease or syndrome.
    Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008234. PubMed ID: 21412917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.